دورية أكاديمية
أعرض في EDS

T cell surface antigen expression on lymphocytes of patients with AIDS during in vitro mitogen stimulation.

التفاصيل البيبلوغرافية
العنوان: T cell surface antigen expression on lymphocytes of patients with AIDS during in vitro mitogen stimulation.
المؤلفون: Munn CG, Reuben JM, Hersh EM, Mansell PW, Newell GR
المصدر: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 1984; Vol. 18 (3), pp. 141-8.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
اللغة: English
بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print Cited Medium: Print ISSN: 0340-7004 (Print) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
أسماء مطبوعة: Publication: Berlin : Springer Verlag
Original Publication: Berlin ; New York, NY : Springer International, c1982-
مواضيع طبية MeSH: Lymphocyte Activation*, Acquired Immunodeficiency Syndrome/*immunology , Antigens, Surface/*analysis , T-Lymphocytes/*immunology, Antibodies, Monoclonal ; Cell Membrane/immunology ; Cells, Cultured ; Homosexuality ; Humans ; Kinetics ; Male ; Mitogens ; Reference Values
مستخلص: Surface marker expression on peripheral blood mononuclear cells (PBMC) was evaluated daily in PHA- and PWM-stimulated cultures of eight AIDS patients and eight normals. Before culture, the patients' cells showed the characteristic decrease in OKT 4+ cells (normals 40.4%, patients 22.3%; P less than 0.001), increase in OKT 8+ cells (normals 27.6%, AIDS 38.4%; P = 0.002), increase in OKT 10+ cells (normals 15.5%, AIDS 42.8%; P = 0.002), and increase in HLA-DR+ cells (normals 11.4%, AIDS 28.7%; P = 0.01). The percentage of OKT 11+ cells remained unchanged, while the percentage of OKT 3+ cells dropped over the first 2 days in PHA but not in PWM cultures of both groups (PHA: normals 69.8% to 35.1%; P = 0.001, AIDS 56.5 to 38.5%; P = 0.001, PWM: normals 62.8%-65.9%, AIDS 66.8% to 63.9%), and recovered in both groups by day 5. In PWM cultures OKT 3+ cells increased significantly in normals but not in AIDS (normals 62.6%-77.7%; P = 0.04, AIDS 61.8 to 48.7%). OKT 4 expression decreased in normal PHA cultures after 1 day (38.9% to 29.6%; P = 0.05) and then recovered by day 5. Its expression increased in AIDS PHA cultures by day 5 (18.0%-41.1%; P less than 0.001). The final percentage of OKT 4+ cells in AIDS cultures was within the normal range (35.0%-49.0%). OKT 8 expression increased in both study groups after PHA stimulation (normals 29.5%-50.4%; P = 0.002, AIDS 37.4%-50.7%; P = 0.02) and in normals but not AIDS after PWM stimulation (normals 28.9%-35.5%; P = 0.004, AIDS 38.5%-35.6%). Because of the relative changes in expression of OKT 4 and OKT 8, the 4/8 ratio declined in the normal PHA cultures (1.89 to 1.03; P = 0.1) and increased in the AIDS cultures (0.68-1.18; P = 0.09). Also, the sum of OKT 4+ and OKT 8+ cells in PHA cultures increased from 68% to 94% whilst expression of OKT 11 remained unchanged, indicating co-expression of these antigens on individual cells. Both PHA-and PWM-stimulated normal cells showed an increase in OKT 10 (PHA 16.0%-53.4%; P = 0.01, PWM 16.1%-33.9%; P = 0.03) and HLA-DR (PHA 8.6%-27.3%; P = 0.03, PWM 12.5%-26.6%; P = 0.07). In AIDS PHA cultures this did not change, and in their PWM cultures OKT 10 expression declined (44.8 to 23.0%; P = 0.05).(ABSTRACT TRUNCATED AT 400 WORDS)
References: Science. 1984 May 4;224(4648):497-500. (PMID: 6200935)
N Engl J Med. 1981 Dec 10;305(24):1431-8. (PMID: 6975437)
Proc Natl Acad Sci U S A. 1983 Nov;80(22):6957-61. (PMID: 6417659)
Am J Med. 1982 Aug;73(2):171-8. (PMID: 7114072)
Nature. 1980 Nov 27;288(5789):391-3. (PMID: 6448962)
Cell Immunol. 1982 Jul 15;71(1):12-26. (PMID: 6183008)
J Immunol. 1981 Apr;126(4):1398-403. (PMID: 6451645)
J Exp Med. 1978 Nov 1;148(5):1440-5. (PMID: 152800)
Proc Natl Acad Sci U S A. 1980 Aug;77(8):4914-7. (PMID: 6968909)
J Immunol. 1979 Mar;122(3):949-53. (PMID: 87422)
Cancer Res. 1983 Feb;43(2):897-904. (PMID: 6600216)
N Engl J Med. 1983 Aug 25;309(8):453-8. (PMID: 6224088)
Cancer Res. 1983 Apr;43(4):1905-9. (PMID: 6219738)
MMWR Morb Mortal Wkly Rep. 1982 Dec 10;31(48):644-6, 652. (PMID: 6819439)
J Immunol. 2013 Jun 1;190(11):5351-3. (PMID: 23687192)
Transplant Proc. 1980 Sep;12(3 Suppl 1):141-6. (PMID: 6968995)
Proc Natl Acad Sci U S A. 1980 Mar;77(3):1588-92. (PMID: 6966400)
J Clin Invest. 1984 Jan;73(1):191-201. (PMID: 6228564)
Ann Intern Med. 1982 Jun;96(6 Pt 1):693-700. (PMID: 6283973)
N Engl J Med. 1981 Dec 10;305(24):1425-31. (PMID: 6272109)
J Immunol. 1981 Sep;127(3):1256-8. (PMID: 6790617)
Vox Sang. 1980 Sep;39(3):121-7. (PMID: 6971014)
MMWR Morb Mortal Wkly Rep. 1982 Jul 9;31(26):353-4, 360-1. (PMID: 6811853)
J Immunol. 1980 Dec;125(6):2402-8. (PMID: 6968783)
Nature. 1982 Nov 18;300(5889):267-9. (PMID: 6815536)
J Clin Invest. 1983 Jul;72(1):398-403. (PMID: 6308051)
J Exp Med. 1979 Dec 1;150(6):1472-82. (PMID: 92523)
Cell. 1982 Oct;30(3):735-43. (PMID: 6982759)
MMWR Morb Mortal Wkly Rep. 1982 Jun 11;31(22):294, 300-1. (PMID: 6810086)
Haematol Blood Transfus. 1983;28:369-79. (PMID: 6602744)
J Exp Med. 1982 Oct 1;156(4):1065-76. (PMID: 6984061)
J Immunol. 1979 Dec;123(6):2894-6. (PMID: 315435)
N Engl J Med. 1979 May 10;300(19):1061-8. (PMID: 34791)
N Engl J Med. 1981 Dec 10;305(24):1439-44. (PMID: 6272110)
J Immunol. 1984 Feb;132(2):735-9. (PMID: 6228598)
Hum Immunol. 1981 Nov;3(3):247-59. (PMID: 6458585)
J Immunol. 1981 Jan;126(1):67-70. (PMID: 6161168)
Ann Intern Med. 1982 Jun;96(6 Pt 1):700-4. (PMID: 6283974)
Science. 1984 May 4;224(4648):500-3. (PMID: 6200936)
Immunol Today. 1983 Aug;4(8):233-6. (PMID: 25290118)
J Immunol. 1983 Jul;131(1):152-7. (PMID: 6190904)
J Immunol. 1981 Apr;126(4):1393-7. (PMID: 6970774)
معلومات مُعتمدة: CA-34674-01 United States CA NCI NIH HHS
المشرفين على المادة: 0 (Antibodies, Monoclonal)
0 (Antigens, Surface)
0 (Mitogens)
تواريخ الأحداث: Date Created: 19840101 Date Completed: 19850215 Latest Revision: 20240426
رمز التحديث: 20240426
مُعرف محوري في PubMed: PMC11039248
DOI: 10.1007/BF00205502
PMID: 6334551
قاعدة البيانات: MEDLINE
الوصف
تدمد:0340-7004
DOI:10.1007/BF00205502